MedTrace Logo

Comparative Effectiveness Trial for Diagnosis of Necrotizing Enterocolitis

NCT05573113 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 169

Last updated 2025-11-21

Study results available
· View outcomes & findings →

Summary

The overall objective of our study is to determine the clinical usefulness of BUS for NEC evaluation in diverse NICU settings.

Conditions

  • Necrotizing Enterocolitis

Interventions

DIAGNOSTIC_TEST

Bowel Ultrasound

Bowel Ultrasound

DIAGNOSTIC_TEST

Abdominal radiograph

Abdominal radiograph

Sponsors & Collaborators

  • University of Kansas Medical Center

    collaborator OTHER

  • American College of Radiology

    collaborator OTHER

  • Children's Mercy Hospital Kansas City

    lead OTHER

Principal Investigators

  • Sherwin Chan, MD, PhD · Children's Mercy Kansas City

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2024-09-23
Completion
2025-09-18
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05573113 on ClinicalTrials.gov